Advertisement

Immunomodulatory Agents from Plants

  • H. Wagner

Part of the Progress in Inflammation Research book series (PIR)

Table of contents

  1. Front Matter
    Pages i-xi
  2. Hildebert Wagner, Stefan Kraus, Ksenija Jurcic
    Pages 1-39
  3. Andreas C. Emmendörffer, Hildebert Wagner, Marie-Luise Lohmann-Matthes
    Pages 89-104
  4. Dieter Melchart, Klaus Linde
    Pages 105-118
  5. Luc A. C. Pieters, Tess E. De Bruyne, Arnold J. Vlietinck
    Pages 137-160
  6. Haruki Yamada, Hiroaki Kiyohara
    Pages 161-202
  7. Yukiko Y. Maeda, Goro Chihara
    Pages 203-221
  8. Rainer Samtleben, Tibor Hajto, Katarina Hostanska, Hildebert Wagner
    Pages 223-241
  9. Marie-Aleth Lacaille-Dubois
    Pages 243-272
  10. Eikai Kyo, Naoto Uda, Shigeo Kasuga, Yoichi Itakura, Hiromichi Sumiyoshi
    Pages 273-288
  11. Sharadini A. Dahanukar, Urmila M. Thatte, Nirmala N. Rege
    Pages 289-323
  12. Pei-Gen Xiao, Chang-Xiao Liu
    Pages 325-356
  13. Back Matter
    Pages 357-372

About this book

Introduction

The human immune system, despite having its own sophisticated defence mecha­ nisms, is inferior to bacteria and viruses with respect to adaptability. Furthermore, our immune system is increasingly exposed to detrimental effects, that is immuno­ suppressive environmental consequences, unhealthy living, and chronic illnesses. Excessive chemotherapy threatens our immune system even further. This situation demands compensatory prophylactic therapeutic regimes. One of these - specific immunostimulation - is more difficult to achieve than the immunosuppression cur­ rently used in transplantation surgery and the medical treatment of autoimmune dis­ eases. The earliest attempts to develop suitable medication for immunostimulation were based on traditional remedies which embodied the accumulated experience of several centuries. Medicinal plants are already being used prophylactically as stan­ dardized and efficacy-optimized preparations for the treatment of various recur­ rent infections, or in combination with chemotherapeutics in standard medical practice. In order to rationally apply immunostimulants of plant origin, however, it is necessary to search for the active principles of these substances and to produce them in a pure form. Because suitable screening methods have become available only recently, research in this field is in its very beginning. Further progress can be expected from systematic basic research on the mechanisms underlying immunomodulation. This also applies to verification of clinical efficacy, which is a prerequisite for the acceptance of medications with purported immunostimulatory properties.

Keywords

alternative medicine cell chemistry clinic drugs medicine oncology pharmaceutical industry pharmacology plant polysaccharide research therapy

Editors and affiliations

  • H. Wagner
    • 1
  1. 1.Institut für pharmazeutische BiologieLudwig-Maximilians-Universität MünchenMünchenGermany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-0348-8763-2
  • Copyright Information Birkhäuser Verlag Basel/Switzerland 1999
  • Publisher Name Birkhäuser, Basel
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-0348-9763-1
  • Online ISBN 978-3-0348-8763-2
  • Buy this book on publisher's site
Industry Sectors
Pharma
Health & Hospitals
Biotechnology